UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063478
Receipt number R000072643
Scientific Title Study to evaluate the effects of the test food on the skin in healthy subjects
Date of disclosure of the study information 2026/11/17
Last modified on 2026/10/30 09:38:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study to evaluate the effects of the test food on the skin in healthy subjects

Acronym

Study to evaluate the effects of the test food on the skin in healthy subjects

Scientific Title

Study to evaluate the effects of the test food on the skin in healthy subjects

Scientific Title:Acronym

Study to evaluate the effects of the test food on the skin in healthy subjects

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects on the skin and the safety of consuming the test food for eight consecutive weeks, using a placebo as a control.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Transepidermal water loss

Key secondary outcomes

Stratum corneum hydration, Skin viscoelasticity


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Take the test food for eight consecutive weeks.

Interventions/Control_2

Take the placebo for eight consecutive weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

64 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Healthy men and women aged 18 to 64 years at the time of obtaining consent
(2) Subjects who perceive their skin to be dry
(3) Subjects who fully understand the purpose and details of the study and voluntarily consent to participate

Key exclusion criteria

Subjects
(1) who habitually consume foods or supplements rich in the active ingredient
(2) who habitually consume foods, pharmaceuticals, or supplements that affect the skin
(3) who habitually use cosmetic products containing ingredients that could affect the study
(4) who have undergone cosmetic medical procedures on the area to be measured
(5) who have undergone cosmetic medical procedures or hormone replacement therapy within one year of the pre-examination
(6) who have undergone procedures affecting the skin at the measurement site within one month of the pre-examination, or who plan to undergo such procedures
(7) who have acquired a suntan within one month of the pre-examination, or who plan to do so
(8) who wash the measurement site with excessive rubbing
(9) who habitually use bath additives
(10) with a disease of the skin at the measurement site
(11) who have body hair on the skin at the measurement site
(12) who exhibit hay fever symptoms on the skin
(13) who experience skin roughness in the area to be measured around the time of menstruation
(14) who habitually consume excessive amounts of alcohol
(15) who smoke or who have smoked within one month of the pre-examination
(16) with an irregular daily routine
(17) planning to travel overseas or take long domestic trips
(18) who have asthma or are likely to develop it
(19) with a serious illness or a history of such illness
(20) at risk of developing an allergy by participating in the study
(21) whose pre-study test results show values significantly outside the reference range
(22) who have participated in other clinical studies within one month prior to obtaining informed consent, or who plan to participate
(23) who are pregnant or plan to become pregnant or breastfeed
(24) deemed unsuitable as subjects based on clinical test results, cardiopulmonary function or their responses to the lifestyle questionnaire
(25) deemed unsuitable as subjects by the principal investigator

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Takeharu
Middle name
Last name Nakahara

Organization

Kikkoman Soyfoods Company

Division name

Product Development Department

Zip code

105-0003

Address

2-1-1 Nishi-Shinbashi, Minato-ku, Tokyo

TEL

03-3519-3200

Email

sfkinousei@mail.kikkoman.co.jp


Public contact

Name of contact person

1st name Mariko
Middle name
Last name Kondo

Organization

EP-DataWeave Co., Ltd.

Division name

Food Development Business Department Trial Planning Section

Zip code

162-0814

Address

Acropolis TOKYO, 6-29 Shin-ogawamachi, Shinjuku-ku, Tokyo

TEL

070-3023-8211

Homepage URL


Email

kondo.mariko793@eps.co.jp


Sponsor or person

Institute

EP-DataWeave Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Kikkoman Soyfoods Company

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Station Clinic Research Ethics Committee

Address

3-12-8, Takaban, Meguro-ku, Tokyo

Tel

03-6452-2712

Email

epmd_fd-erb@eps.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 10 Month 22 Day

Date of IRB


Anticipated trial start date

2026 Year 11 Month 18 Day

Last follow-up date

2027 Year 03 Month 19 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 10 Month 30 Day

Last modified on

2026 Year 10 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072643